Novo Nordisk NVO is scheduled to report its second-quarter 2025 results before the opening bell on Aug. 6, 2025. The Zacks ...

Novo Nordisk (NVO) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term. Shares ...

Novo Nordisk A/S (NVO) on Wednesday reported second-quarter profit of $4.03 billion. On a per-share basis, the Bagsvaerd, ...

The second-quarter earnings season for the drug and biotech sector accelerated last week and will be in full swing this week, ...

For Immediate ReleaseChicago, IL – May 10, 2023 – Zacks Equity Research shares Novo Nordisk A/S NVO as the Bull of the Day and Nutrien NTR as the Bear of the Day. In addition, Zacks Equity ...

For Immediate Release Chicago, IL – March 10, 2023 – Today, Zacks Equity Research discusses J&J JNJ, Novo Nordisk NVO, AstraZeneca AZN, Novartis NVS and Sanofi SNY. Industry: Big Pharma ...

Tempus AI TEM and NVIDIA NVDA are both actively working at the intersection of AI and healthcare. Tempus AI, while advancing ...

TEM surges 91.8% YTD on rapid AI-healthcare growth, while NVDA fuels the sector with cutting-edge infrastructure and partnerships.

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Shares of Novo Nordisk have underperformed the Zacks Large Cap Pharmaceuticals industry over the past year (-37% vs. +3%). The company’s failure to meet the weight-loss target with CagriSema ...